CD14 and plasma cell myeloma: Percentage of monocytes (CD3–CD20–CD14+), previously found to decrease in the BM of patients with myeloma relative to healthy individuals (10), was elevated in short-OS patients compared with long-OS patients at relapse (Figure 3A).